Literature DB >> 26616867

Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.

Luis Agulló1, Sunny Malhotra2, Nicolás Fissolo2, Xavier Montalban2, Manuel Comabella2.   

Abstract

The tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) gene encodes the TNF-R1, one of the main TNF receptors that mediates its inflammatory actions. In a recent study, serum levels of the soluble TNF-R1 and mRNA levels of the full-length receptor were found to be significantly increased in multiple sclerosis (MS) patients carrying the R92Q mutation. Interestingly, R92Q-mutated patients were younger at disease onset and progressed slower as compared to non-carriers. Building on these previous findings, here we aimed to investigate by means of both in silico and in vitro approaches the mechanisms relating the R92Q substitution with functional changes of the receptor and their potential effects modulating MS disease course. Models of the extracellular domains of the human TNF-R1 and human TNF-R1 carrying the R92Q mutation, alone or bound to TNF, were constructed and submitted to molecular dynamics. TRAF2 and CASP3 mRNA expression levels were determined by real-time PCR in peripheral blood mononuclear cells (PBMC) from 61 MS patients, 9 R92Q carriers and 52 non-carriers (CT and CC genotypes for SNP rs4149584, respectively). Molecular dynamic studies revealed that the R92Q mutation increased the contact area between receptor and TNF (1070 and 1388Å(2) for native and mutated receptor) and decreased the distance between them (28.7 to 27.9Å), while Van der Waals and electrostatic interaction energies were increased. In PBMC from MS patients carrying the R92Q mutation, CASP3 mRNA expression levels were significantly increased compared to non-carriers, whereas a trend was observed for TRAF2. These data suggest that the R92Q mutation gives rise to a stronger interaction between the receptor and its ligand, which results in the potentiation of TNF-mediated pathways. Although further studies are needed, these functional changes may be related with the modulation in disease course reported in MS patients carrying the R92Q mutation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CASP3; Molecular dynamics; Multiple sclerosis; R92Q mutation; TNF receptor 1; TNF receptor-associated periodic syndrome; TRAF2; Tumor necrosis factor; mRNA expression

Mesh:

Substances:

Year:  2015        PMID: 26616867     DOI: 10.1016/j.jneuroim.2015.10.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Inflammation and Trajectory of Renal Function in Community-Dwelling Older Adults.

Authors:  Shabnam Salimi; Michelle D Shardell; Stephen L Seliger; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2018-01-23       Impact factor: 5.562

2.  Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene.

Authors:  Estíbaliz Ruiz-Ortiz; Estíbaliz Iglesias; Alessandra Soriano; Segundo Buján-Rivas; Marta Español-Rego; Raul Castellanos-Moreira; Adrià Tomé; Jordi Yagüe; Jordi Antón; José Hernández-Rodríguez
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

3.  VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these malignant tumors.

Authors:  Alexander Autenshlyus; Sergey Arkhipov; Elena Mikhailova; Valentina Arkhipova; Nikolay Varaksin
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

4.  Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network.

Authors:  Carla Gaggiano; Donato Rigante; José Hernández-Rodríguez; Antonio Vitale; Maria Tarsia; Alessandra Soriano; Giuseppe Lopalco; Florenzo Iannone; Masen Abdel Jaber; Roberto Giacomelli; Ewa Wiȩsik-Szewczyk; Marco Cattalini; Micol Frassi; Matteo Piga; Gaafar Ragab; Jurgen Sota; Fiammetta Zunica; Alberto Floris; Vito Sabato; Mohamed Tharwat Hegazy; Olga Araújo; Laura Pelegrín; Alessandra Fabbiani; Alessandra Renieri; Salvatore Grosso; Claudia Fabiani; Bruno Frediani; Luca Cantarini
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-09-09       Impact factor: 5.346

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.